Stay updated with breaking news from Mark Emalfarb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Ladies and gentlemen, good evening, and welcome to Dyadic International's Q1 2024 Conference Call. Currently, all participants are in a listen-only mode.
Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07.
JUPITER, Fla., March 28, 2024 -- Dyadic International, Inc. , a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and...
Dyadic International, Inc. Chief Executive Officer, Mark Emalfarb, appeared on The Street Podcast for an in-depth conversation about the company. During the interview, he highlighted that Dyadic had...
The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman primate models compared...